Comparing the immunogenicity of COVID-19 infection and vaccination in pregnant women as measured by anti-S IgG.

ABSTRACT:

Background

Pregnancy is a critical time for women, making them more susceptible to infectious diseases like COVID-19. This study aims to determine the immunogenicity of COVID-19 in pregnant women who have been infected compared to those who have received the inactive COVID-19 vaccine.

Materials and methods

In this retrospective cohort study, pregnant women who received the inactivated COVID-19 vaccine (Sinopharm) and those with a history of COVID-19 infection during pregnancy were studied. Participants who had experienced stillbirth, received different COVID-19 vaccines, or had intrauterine fetal death were excluded from the study. Overall, the study included 140 participants. The participants were divided into two groups of 70 participants - pregnant women who received the

SUBMITTER: Hemati Z 

PROVIDER: S-EPMC11386373 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature